Bacterial Outer Membrane Vesicles Presenting Programmed Death 1 for Improved Cancer Immunotherapy <i>via</i> Immune Activation and Checkpoint Inhibition
2020 · ACS Nano · 256 citations
https://doi.org/10.1021/acsnano.0c03776
Y
Yujing Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
117
Papers
3.6K
Citations
30
h-index
44
i10-index
Yujing Li is an academic researcher from University of Science and Technology of China. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Pregnancy and preeclampsia studies & Reproductive System and Pregnancy. The author has an h-index of 30, co-authored 100 publications.
ORCID: 0000-0002-3223-769XPapers by this author
worksGrowth hormone activates PI3K/Akt signaling and inhibits ROS accumulation and apoptosis in granulosa cells of patients with polycystic ovary syndrome
2020 · Reproductive Biology and Endocrinology · 238 citations
https://doi.org/10.1186/s12958-020-00677-x
Amplification of USP13 drives ovarian cancer metabolism
2016 · Nature Communications · 127 citations
https://doi.org/10.1038/ncomms13525
Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD
2016 · Science China Life Sciences · 61 citations
https://doi.org/10.1007/s11427-015-4997-y
Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer
2018 · Nature Communications · 60 citations
https://doi.org/10.1038/s41467-018-07264-0
Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II
2018 · Nature Communications · 49 citations
https://doi.org/10.1038/s41467-018-06811-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat